Series B funding supports programmable mRNA platform with lead candidate showing promise in solid tumors Massachusetts-based Strand Therapeutics completed a $153 million Series B financing
Pfizer and BioNTech have reached a substantial $740 million settlement agreement with CureVac to resolve a complex patent dispute involving foundational mRNA technology that underpins
The digital health sector is experiencing a notable resurgence, with U.S. startups raising $6.4 billion in the first half of 2025, marking a modest but
HistoSonics has secured a transformative investment that values the innovative medical device company at $2.25 billion, with a consortium led by Johnson & Johnson Development
